Spots Global Cancer Trial Database for Radiotherapy in Primary Mediastinal Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Radiotherapy in Primary Mediastinal Lymphoma
Official Title: Adjuvant Radiotherapy in Primary Mediastinal Lymphoma in Patients That Received R-CHOP
Study ID: NCT01230008
Interventions
Study Description
Brief Summary: The use of Rituximab has been proposed to be useful and avoid the use of radiotherapy in diffuse large B-cell lymphoma with bulky disease.We assess efficacy of adjuvant radiotherapy in patients treated with R-CHOP
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Oncology Research Unit, Mèxico DF, DF, Mexico
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
